A nurse is talking with the parents of a 2-month-old infant who have chosen to not immunize the infant. Which of the following responses should the nurse make?

Choice A reason: Beneficence, acting for patient benefit, is not breached, as both clients receive care and supplies, albeit differently. Unequal distribution reflects access issues, not failure to promote well-being, making beneficence less relevant than justice in addressing this ethical concern.
Choice B reason: Nonmaleficence, avoiding harm, is not violated, as both clients access supplies without direct harm. The inequality in delivery method raises fairness concerns, not harm, making justice the primary ethical principle breached in this scenario of differential treatment.
Choice C reason: Justice, ensuring fair treatment, is breached when one client receives supplies directly and another must seek them externally due to insurance status. This inequality in resource access violates equitable care principles, critical in healthcare ethics to ensure fairness across patient populations.
Choice D reason: Autonomy, respecting patient choices, is not breached, as both clients receive care consistent with their needs. The issue lies in unequal resource access, not decision-making restrictions, making justice the relevant ethical principle over autonomy in this scenario.

Choice A reason: Calcium gluconate IV reverses magnesium sulfate toxicity, which causes respiratory depression or arrhythmias due to excessive magnesium. Calcium restores neuromuscular and cardiac function by competing with magnesium, preventing life-threatening complications like respiratory arrest in preeclampsia management.
Choice B reason: Positioning supine is inappropriate, as it does not address magnesium toxicity and may worsen respiration in preeclampsia. Semi-Fowler’s position optimizes breathing, while toxicity requires pharmacological reversal with calcium gluconate, not positional changes, to manage life-threatening symptoms effectively.
Choice C reason: IV dextrose is irrelevant for magnesium toxicity, which affects neuromuscular function, not glucose levels. Dextrose treats hypoglycemia, not applicable here. Magnesium overdose requires calcium to counteract effects, making dextrose an ineffective intervention in preeclampsia-related toxicity management.
Choice D reason: Methylergonovine, a uterotonic, is contraindicated in preeclampsia, as it increases blood pressure, risking hypertensive crisis. It treats postpartum hemorrhage, not magnesium toxicity, which requires calcium gluconate to reverse neuromuscular depression, ensuring safety in preeclampsia management.